CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Zhengye Biotechnology Receives Nasdaq Letter for Minimum Bid Price Deficiency

RegulatoryNegative
AI Analysis

Summary

Zhengye Biotechnology received a Nasdaq letter indicating a minimum bid price deficiency, which could affect the company's continued listing status on the exchange.

Outcome Details

Nasdaq minimum bid price deficiency notice

Importance:6/10
Sentiment:
-0.70
Nasdaq compliancestock delisting riskregulatory
Related Companies

Read the original article

Published by yahoo_finance on June 4, 2026 8:55 PM

Read Original